Knowledge

Paul Ehrlich Institute

Source 📝

330: 33: 523: 293:, one of Germany's most prominent medical researchers at the time, as its first director. The institute was founded specifically to provide a platform for Ehrlich's research. In 1899, it moved to 548: 309:. In 1947, the institute was renamed the Paul Ehrlich Institute in honour of its founding director. In 1987, the institute moved from Paul-Ehrlich-Straße in Frankfurt to 442: 563: 558: 469: 487: 568: 553: 240: 455: 97: 502: 116: 69: 543: 538: 345:. The medicinal products in the responsibility of the PEI are: vaccines for humans and animals, medicinal products containing 76: 54: 47: 261:, and was located in Frankfurt for most of the 20th century. It is named for its founding director, the immunologist and 573: 83: 65: 244: 301:). After Germany had become a republic in 1919, it was renamed the National Institute for Experimental Therapy ( 583: 578: 382: 337:
The regulatory tasks of the Paul Ehrlich Institute include the marketing authorisation of particular groups of
232: 353:
for therapy and products for diagnostic tests, blood and blood products and tissue and medicinal products for
306: 43: 466: 484: 409: 388: 90: 166: 415: 338: 491: 473: 397: 421: 342: 201: 329: 229:
Paul-Ehrlich-Institut – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel
135:
Paul-Ehrlich-Institut – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel
532: 376: 310: 254: 176: 17: 370: 354: 290: 266: 262: 32: 346: 358: 350: 294: 258: 305:). Ehrlich received numerous honours in Germany and was awarded the 1908 278: 249: 236: 443:"Paul-Ehrlich-Institut belegt Platz 2 im regionalen Arbeitgeber-Ranking" 180: 282: 239:
and biomedicines. It was founded in 1896 and is subordinate to the
328: 319:
Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel
297:
and was renamed the Royal Institute for Experimental Therapy (
26: 503:
Klaus Cichutek: Neuer Präsident des Paul-Ehrlich-Instituts
518: 277:
The Paul Ehrlich Institute was founded on 1 June 1896 in
215: 285:
as the Institute for Serum Research and Serum Testing (
235:, medical regulatory body and research institution for 313:, a suburb south of Frankfurt. In 2009, the addition 211: 194: 186: 172: 162: 144: 139: 303:Staatliches Institut für Experimentelle Therapie 299:Königliches Institut für experimentelle Therapie 549:World Health Organization collaborating centres 8: 287:Institut für Serumforschung und Serumprüfung 247:for quality assurance of blood products and 129: 400:(1984 Nobel laureate in medicine) 1966–1969 373:(1908 Nobel laureate in medicine) 1896–1915 117:Learn how and when to remove this message 434: 128: 53:Please improve this article by adding 253:diagnostic devices. It is located in 7: 25: 564:Organizations established in 1896 333:Entrance of the institute in 2022 315:Bundesamt für Sera und Impfstoffe 559:Organisations based in Frankfurt 31: 1: 569:Research institutes in Berlin 554:Organisations based in Berlin 55:secondary or tertiary sources 418:1999–2009 (acting 1999–2001) 524:PEI Annual Report 2007-2008 406:Hans Dieter Brede 1974–1987 357:, somatic cell therapy and 600: 519:Official Website (English) 241:Federal Ministry of Health 403:Günther Heymann 1969–1973 394:Günther Heymann 1962–1966 134: 365:Directors and Presidents 245:WHO Collaborating Centre 66:"Paul Ehrlich Institute" 544:German federal agencies 307:Nobel Prize in medicine 150:; 128 years ago 539:Paul Ehrlich Institute 334: 225:Paul Ehrlich Institute 130:Paul Ehrlich Institute 42:relies excessively on 456:Collaborating centres 332: 289:), with immunologist 243:. The institute is a 167:Government of Germany 18:Paul-Ehrlich-Institut 341:and the approval of 574:Virology institutes 485:PEI Official Duties 231:, PEI) is a German 131: 490:2011-02-21 at the 472:2011-02-21 at the 339:medicinal products 335: 221: 220: 127: 126: 119: 101: 16:(Redirected from 591: 506: 505:, aerzteblatt.de 500: 494: 482: 476: 464: 458: 453: 447: 446: 439: 195:Agency executive 158: 156: 151: 132: 122: 115: 111: 108: 102: 100: 59: 35: 27: 21: 599: 598: 594: 593: 592: 590: 589: 588: 584:1896 in science 579:1896 in Germany 529: 528: 515: 510: 509: 501: 497: 492:Wayback Machine 483: 479: 474:Wayback Machine 465: 461: 454: 450: 441: 440: 436: 431: 398:Niels Kaj Jerne 367: 343:clinical trials 327: 275: 207: 154: 152: 149: 140:Agency overview 123: 112: 106: 103: 60: 58: 52: 48:primary sources 36: 23: 22: 15: 12: 11: 5: 597: 595: 587: 586: 581: 576: 571: 566: 561: 556: 551: 546: 541: 531: 530: 527: 526: 521: 514: 513:External links 511: 508: 507: 495: 477: 459: 448: 433: 432: 430: 427: 426: 425: 422:Klaus Cichutek 419: 416:Johannes Löwer 413: 410:Reinhard Kurth 407: 404: 401: 395: 392: 389:Richard Prigge 386: 380: 374: 366: 363: 361:cell therapy. 326: 323: 274: 271: 233:federal agency 219: 218: 213: 209: 208: 206: 205: 202:Klaus Cichutek 198: 196: 192: 191: 188: 184: 183: 174: 170: 169: 164: 160: 159: 146: 142: 141: 137: 136: 125: 124: 39: 37: 30: 24: 14: 13: 10: 9: 6: 4: 3: 2: 596: 585: 582: 580: 577: 575: 572: 570: 567: 565: 562: 560: 557: 555: 552: 550: 547: 545: 542: 540: 537: 536: 534: 525: 522: 520: 517: 516: 512: 504: 499: 496: 493: 489: 486: 481: 478: 475: 471: 468: 463: 460: 457: 452: 449: 444: 438: 435: 428: 423: 420: 417: 414: 411: 408: 405: 402: 399: 396: 393: 390: 387: 384: 381: 378: 377:Wilhelm Kolle 375: 372: 369: 368: 364: 362: 360: 356: 352: 348: 344: 340: 331: 324: 322: 320: 316: 312: 311:Langen, Hesse 308: 304: 300: 296: 292: 288: 284: 280: 272: 270: 268: 264: 260: 256: 255:Langen, Hesse 252: 251: 246: 242: 238: 234: 230: 226: 217: 214: 210: 203: 200: 199: 197: 193: 189: 185: 182: 178: 177:Langen, Hesse 175: 171: 168: 165: 161: 147: 143: 138: 133: 121: 118: 110: 99: 96: 92: 89: 85: 82: 78: 75: 71: 68: –  67: 63: 62:Find sources: 56: 50: 49: 45: 40:This article 38: 34: 29: 28: 19: 498: 480: 462: 451: 437: 424:2009–present 383:Richard Otto 371:Paul Ehrlich 355:gene therapy 336: 318: 317:was renamed 314: 302: 298: 291:Paul Ehrlich 286: 276: 267:Paul Ehrlich 248: 228: 224: 222: 173:Headquarters 163:Jurisdiction 113: 104: 94: 87: 80: 73: 61: 41: 467:PEI History 263:Nobel Prize 204:, President 155:1 June 1896 148:1 June 1896 533:Categories 429:References 347:antibodies 325:Activities 216:www.pei.de 107:March 2021 77:newspapers 44:references 445:. pei.de. 412:1987–1999 391:1949–1962 385:1938–1948 379:1917–1935 359:xenogenic 351:allergens 295:Frankfurt 265:laureate 259:Frankfurt 227:(German: 187:Employees 488:Archived 470:Archived 279:Steglitz 250:in vitro 237:vaccines 273:History 257:, near 212:Website 181:Germany 153: ( 91:scholar 283:Berlin 145:Formed 93:  86:  79:  72:  64:  98:JSTOR 84:books 223:The 190:≈800 70:news 46:to 535:: 349:, 321:. 281:, 269:. 179:, 57:. 157:) 120:) 114:( 109:) 105:( 95:· 88:· 81:· 74:· 51:. 20:)

Index

Paul-Ehrlich-Institut

references
primary sources
secondary or tertiary sources
"Paul Ehrlich Institute"
news
newspapers
books
scholar
JSTOR
Learn how and when to remove this message
Government of Germany
Langen, Hesse
Germany
Klaus Cichutek
www.pei.de
federal agency
vaccines
Federal Ministry of Health
WHO Collaborating Centre
in vitro
Langen, Hesse
Frankfurt
Nobel Prize
Paul Ehrlich
Steglitz
Berlin
Paul Ehrlich
Frankfurt

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.